Results 81 to 90 of about 3,023 (195)

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton, Michael R. Gionfriddo, Gail B. Rattinger, Yuan Fang, Mia E. Lussier   +4 more
wiley   +1 more source

A comparative study on efficacy and safety of glycopyrronium bromide + salmeterol/fluticasone and tiotropium bromide + salmeterol/fluticasone in chronic obstructive pulmonary disease

, 2019
Objective: To compare the effect of tiotropium bromide and glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease. Methods: This was an open labeled Randomized controlled trial study.
Srivastava, Rahul, Ghosh, Dibyadeb, Kumar, Deepak, Khare, A.K., Raman, Ram Babu   +4 more
core   +1 more source

sj-docx-1-ems-10.1177_14690667231217879 - Supplemental material for Simultaneous quantification of tiotropium bromide impurities G + H in capsule formulation by LC-MS/MS

, 2023
Supplemental material, sj-docx-1-ems-10.1177_14690667231217879 for Simultaneous quantification of tiotropium bromide impurities G + H in capsule formulation by LC-MS/MS by Serdar Erkol, Müge Güleli, Cem Çalışkan and Sevgi Kocaoba in European Journal of ...
Cem Çalışkan (17538359), Serdar Erkol (17538353), Müge Güleli (17538356), Sevgi Kocaoba (17538362)   +3 more
core   +1 more source

Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden

, 2015
OBJECTIVES: The objective of this study was to compare the cost effectiveness of once-daily Seebri Breezhaler(®) (glycopyrronium bromide) 50 µg with Spiriva(®) (tiotropium bromide) 18 µg in the maintenance treatment of chronic obstructive pulmonary ...
Goyal, Pankaj, Gruenberger, Jean-Bernard, Price, David, Ställberg, Björn,, Asukai, Yumi, Costa-Scharplatz, Madlaina   +5 more
core   +1 more source

PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION

Фармакоэкономика, 2016
The purpose of this study was to conduct the analysis of the structure and the rationality of cost in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD) in Krasnoyarsk region.Materials and methods ...
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva   +5 more
doaj   +1 more source

Tiotropium Bromide Improves Neutrophilic Asthma by Recovering Histone Deacetylase 2 Activity. [PDF]

J Korean Med Sci, 2023
An TJ, Kim JH, Hur J, Park CK, Lim JU, Kim S, Rhee CK, Yoon HK.   +7 more
europepmc   +1 more source

Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro

, 2008
Kazuhito Asano1, Yusuke Shikama2, Yasuhiro Shibuya2, Hiroaki Nakajima2, Ken-ichi Kanai3, Naohiro Yamada3, Harumi Suzaki31Division of Physiology, School of Nursing and Rehabilitation Sciences; 2Respiratory Disease Center, Showa University Northern ...
Yusuke Shikama, Hiroaki Nakajima, Ken-ichi Kanai, et al, Yasuhiro Shibuya, Kazuhito Asano   +5 more
core  

DEVELOPMENT AND VALIDATION OF UV-SPECTROSCOPIC METHOD FOR ESTIMATION OF TIOTROPIUM BROMIDE IN API AND PHARMACEUTICAL DOSAGE FORM

, 2020
Objective: The current work intended towards the developed and validated UV spectrophotometric method for the estimation of Tiotropium Bromide in API and pharmaceutical formulation. Methods: The UV spectrum of tiotropium bromide in methanol shows maximum
SHINDE, BHAGYASHRI S., KALSHETTI, M. S., KOKANE, ANJALI P.   +2 more
core  

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice

Медицинский совет, 2019
Today, chronic obstructive pulmonary disease is the fourth global cause of deaths worldwide. A number of studies showed that 11 to 16 million people might suffer from the chronic obstructive pulmonary disease in Russia.
Р. A. Balunov, A. N. Khitrov
doaj   +1 more source

Efficacy and safety of carvedilol in combination with bronchodilators in patients with CHF of ischemic origin and COPD.

Клиническая практика, 2019
Objective. To study the effectiveness of carvedilol, tiotropium bromide and indacaterol in complex therapy on clinical and functional parameters in patients with CHF of ischemic origin in combination with COPD. Material and methods. The study included
Vladimir V. Evdokimov, A. G. Evdokimova, E. N. Yushchuk   +2 more
doaj   +1 more source